Screener
Iovance Biotherapeutics, Inc. IOVA Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
FAQ
- What is Iovance Biotherapeutics, Inc.'s gross profit?
- Iovance Biotherapeutics, Inc. (IOVA) reported gross profit of $55.72M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s gross profit changed year-over-year?
- Iovance Biotherapeutics, Inc.'s gross profit increased by 403.3% year-over-year, from $11.07M to $55.72M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s gross profit?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s gross profit has grown at a 2306.2% compound annual growth rate (CAGR), from $156K to $90.32M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Iovance Biotherapeutics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude